ACOR - Acorda Therapeutics beats by $0.41 beats on revenue May, 02 2019 06:02 AM Acorda Therapeutics Inc. Acorda Therapeutics (NASDAQ:ACOR): Q1 Non-GAAP EPS of -$0.56 beats by $0.41; GAAP EPS of -$1.00.More news on: Acorda Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...